ARCHIVES

DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”

This article is from The Cancer Letter archive.

Vol. 08 No. 25 | June 18, 1982

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Community Assn. Meeting Includes Provocative Workshops

January 31, 1975

Advances Found In Treatment Of Aerodigestive Cancers

May 25, 2001

NCI Statisticians Disputes Bross Claim

April 27, 1979

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

June 10, 1983